Medpace Holdings, Inc. (MEDP) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1239379,
    "name": "Medpace Holdings, Inc.",
    "stock_name": "Medpace Holdings, Inc.",
    "full_name": "Medpace Holdings, Inc.",
    "name_url": "stocks-analysis/medpace-holdings-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "544.77",
    "chg": -38.93,
    "chgp": "-6.67%",
    "dir": -1,
    "prev_price": "583.70",
    "mcapval": "13,858.78",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 3205,
    "indexname": "S&P 500",
    "isin": "US58506Q1094",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.16 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medpace-holdings-inc-1239379-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Medpace Holdings Hits New 52-Week High at $546.81",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medpace-holdings-hits-new-52-week-high-at-54681-3588400",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MedpaceHoldings_priceRelatedfactors_3588400.png",
        "date": "2025-10-02 22:38:50",
        "description": "Medpace Holdings, Inc. achieved a new 52-week high of USD 546.81 on October 1, 2025, reflecting strong market performance with a 34.07% increase over the past year. The company, with a market cap of USD 13,859 million, demonstrates favorable financial metrics, including a P/E ratio of 21.00 and a return on equity of 242.70%."
      },
      {
        "title": "Medpace Holdings Reaches New 52-Week High of $514.74",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medpace-holdings-reaches-new-52-week-high-of-51474-3586065",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MedpaceHoldings_priceRelatedfactors_3586065.png",
        "date": "2025-10-01 16:42:04",
        "description": "Medpace Holdings, Inc. achieved a new 52-week high of USD 514.74 on September 30, 2025, reflecting strong market performance with a 1-year increase of 26.74%. The company, with a market cap of USD 13,859 million, showcases impressive financial metrics, including a return on equity of 242.70%."
      },
      {
        "title": "Is Medpace Holdings, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-medpace-holdings-inc-technically-bullish-or-bearish-3547315",
        "imagepath": "",
        "date": "2025-09-20 19:52:35",
        "description": "As of 31 July 2025, the technical trend for Medpace Holdings, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, and both the Bollinger Bands and Dow Theory confirm a bullish stance across these time frames. Daily moving averages also indicate bullish momentum. However, the KST is bullish on a weekly basis but mildly bearish monthly, and the OBV shows a mildly bearish trend over the month. \n\nMedpace has significantly outperformed the S&P 500, with a year-to-date return of 51.08% compared to the S&P 500's 12.22%, and a three-year return of 232.70% versus 70.41% for the benchmark. Overall, the current technical stance is bullish, reflecting strong momentum despite some mixed signals in the KST and OBV...."
      },
      {
        "title": "Is Medpace Holdings, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-medpace-holdings-inc-overvalued-or-undervalued-3543713",
        "imagepath": "",
        "date": "2025-09-20 18:26:39",
        "description": "As of 3 September 2025, the valuation grade for Medpace Holdings, Inc. has moved from expensive to very expensive, indicating a significant concern regarding its valuation. The company appears to be overvalued, particularly when considering its P/E ratio of 21, which is notably higher than peers such as ICON plc with a P/E of 14.64 and Booz Allen Hamilton Holding Corp. at 15.81. Additionally, Medpace's EV to EBITDA ratio stands at 16.73, again exceeding the industry averages, which raises further doubts about its current valuation.\n\nIn comparison to the S&P 500, Medpace has shown impressive returns, with a YTD return of 51.08% compared to the index's 12.22%, and a remarkable 3Y return of 232.70% against 70.41% for the S&P 500. However, despite these strong performance metrics, the high valuation ratios suggest that the stock may not be a sustainable investment at its current price of 501.94...."
      },
      {
        "title": "Medpace Holdings Hits New 52-Week High of $506.55, Showcasing Strong Growth",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medpace-holdings-hits-new-52-week-high-of-50655-showcasing-strong-growth-3531532",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/MedpaceHoldings_priceRelatedfactors_3531532.png",
        "date": "2025-09-18 13:22:19",
        "description": "Medpace Holdings, Inc. achieved a new 52-week high of USD 506.55 on September 17, 2025, reflecting strong market performance with a 22.71% increase over the past year. The company, with a market cap of USD 13,859 million, showcases impressive financial metrics, including a return on equity of 242.70%."
      }
    ],
    "total": 10,
    "sid": "1239379",
    "stock_news_url": "https://www.marketsmojo.com/news/medpace-holdings-inc-1239379"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Medpace Holdings Hits New 52-Week High at $546.81

2025-10-02 22:38:50

Medpace Holdings, Inc. achieved a new 52-week high of USD 546.81 on October 1, 2025, reflecting strong market performance with a 34.07% increase over the past year. The company, with a market cap of USD 13,859 million, demonstrates favorable financial metrics, including a P/E ratio of 21.00 and a return on equity of 242.70%.

Medpace Holdings Reaches New 52-Week High of $514.74

2025-10-01 16:42:04

Medpace Holdings, Inc. achieved a new 52-week high of USD 514.74 on September 30, 2025, reflecting strong market performance with a 1-year increase of 26.74%. The company, with a market cap of USD 13,859 million, showcases impressive financial metrics, including a return on equity of 242.70%.

Is Medpace Holdings, Inc. technically bullish or bearish?

2025-09-20 19:52:35

As of 31 July 2025, the technical trend for Medpace Holdings, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, and both the Bollinger Bands and Dow Theory confirm a bullish stance across these time frames. Daily moving averages also indicate bullish momentum. However, the KST is bullish on a weekly basis but mildly bearish monthly, and the OBV shows a mildly bearish trend over the month. Medpace has significantly outperformed the S&P 500, with a year-to-date return of 51.08% compared to the S&P 500's 12.22%, and a three-year return of 232.70% versus 70.41% for the benchmark. Overall, the current technical stance is bullish, reflecting strong momentum despite some mixed signals in the KST and OBV....

Is Medpace Holdings, Inc. overvalued or undervalued?

2025-09-20 18:26:39

As of 3 September 2025, the valuation grade for Medpace Holdings, Inc. has moved from expensive to very expensive, indicating a significant concern regarding its valuation. The company appears to be overvalued, particularly when considering its P/E ratio of 21, which is notably higher than peers such as ICON plc with a P/E of 14.64 and Booz Allen Hamilton Holding Corp. at 15.81. Additionally, Medpace's EV to EBITDA ratio stands at 16.73, again exceeding the industry averages, which raises further doubts about its current valuation. In comparison to the S&P 500, Medpace has shown impressive returns, with a YTD return of 51.08% compared to the index's 12.22%, and a remarkable 3Y return of 232.70% against 70.41% for the S&P 500. However, despite these strong performance metrics, the high valuation ratios suggest that the stock may not be a sustainable investment at its current price of 501.94....

Medpace Holdings Hits New 52-Week High of $506.55, Showcasing Strong Growth

2025-09-18 13:22:19

Medpace Holdings, Inc. achieved a new 52-week high of USD 506.55 on September 17, 2025, reflecting strong market performance with a 22.71% increase over the past year. The company, with a market cap of USD 13,859 million, showcases impressive financial metrics, including a return on equity of 242.70%.

View All News